The two-step auto-injector Comforjet® has become the first auto-injector in China to pass the Class A pharmaceutical packaging certification and successfully launch on the market, thanks to multiple groundbreaking innovations. It has already served numerous pharmaceutical companies with over a dozen products, covering GLP-1 and autoimmune drugs.

The AI fully automated production line launched this time, with "unmanned, high precision, and zero defects" as its core competitiveness, redefines the new standards for domestic automatic injection pen manufacturing. Li Yunfeng, General Manager of Jingwei Technology, stated, "The yield rate of this production line has stabilized at 98.7%, and the annual production capacity reserved in the workshop exceeds 100 million units, providing a strong guarantee for large-scale delivery to global pharmaceutical companies."

Hengrui Medicine takes the AI production line as the core hub, linking upstream and downstream to build a one-stop solution, promoting the collaborative development of the industry, and achieving three major breakthroughs: cost advantage, technological independence, and model innovation.